Murrieta Genomics Spinout SimplSeq Files Fourth Patent Application Around Novel Sample Preparation Technology
Share Article
Sequencing. Simplified. MURRIETA, Calif. (PRWEB) December 22, 2020
Murrieta Genomics has announced that SimplSeq, Inc., a wholly owned subsidiary, has filed its fourth patent application to protect a new sample preparation technology that is designed to simplify the process for extracting, isolating, purifying and replicating DNA and RNA from biologic samples.
“Our internal validation testing has delivered some very exciting data, and we wanted to share that with collaborators,” stated John Powers, CEO of SimplSeq. “When we delivered these results to our legal team, they immediately informed us that we needed to file an additional application with the Patent and Trademark Office.”